GI-AHP deal may catalyze more big-time acquisitions.
Brower
V
V
D005164:Factor IX / Q000096:biosynthesis / Q000627:therapeutic use; D005818:Genetic Engineering / Q000191:economics; D002836:Hemophilia B / Q000628:therapy; D006801:Humans; D007221:Industry / Q000191:economics / Q000458:organization & administration*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D011994:Recombinant Proteins; D005164:Factor IX